MET
61
-2
WMB
59
4
XRX
23
-9
LH
52
12
HRB
61
9
ECL
50
3
CL
54
4
SYF
65
-2
XRAY
26
-3
DGX
53
3
TEL
58
-2
GOOG
71
-4
PEP
39
12
PPL
69
2
V
62
-2
EL
33
-3
WBA
41
-3
IFF
42
-2
R
68
-2
MCHP
43
-12
MET
61
-2
WMB
59
4
XRX
23
-9
LH
52
12
HRB
61
9
ECL
50
3
CL
54
4
SYF
65
-2
XRAY
26
-3
DGX
53
3
TEL
58
-2
GOOG
71
-4
PEP
39
12
PPL
69
2
V
62
-2
EL
33
-3
WBA
41
-3
IFF
42
-2
R
68
-2
MCHP
43
-12
Financhill
Back

Immunovant Stock Predictions

Invest Where Innovation Meets Real Demand

Disclosure: *This is a paid advertisement for Boxabl's Regulation A offering. Please read the offering circular at invest.boxabl.com. This is a message from Boxabl.
Sell
20

IMVT
Immunovant

Last Price:
$14.45
Seasonality Move:
14.56%

7 Day Trial

ALL ACCESS PASS

$ 7

Disrupting a Trillion-Dollar Industry

Disclosure: *This is a paid advertisement for Boxabl's Regulation A offering. Please read the offering circular at invest.boxabl.com. This is a message from Boxabl.

Immunovant Stock Forecast

  • Over the next 52 weeks, Immunovant has on average historically risen by 68.6% based on the past 5 years of stock performance.
  • Immunovant has risen higher in 2 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
  • Is Immunovant Stock Undervalued?
    The current Immunovant [IMVT] share price is $14.46. The Score for IMVT is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
  • IMVT is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.

Will Immunovant Stock Go Up Next Year?

  • Over the next 52 weeks, Immunovant has on average historically risen by 68.6% based on the past 5 years of stock performance.

Immunovant Stock Rating

Sell
20
Immunovant (IMVT) is a Sell

Is Immunovant overpriced?

  • Immunovant has risen higher in 2 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%

Immunovant Stock Price History

Is IMVT stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IMVT is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
immunovant.com

52-Week Data

52-Week High:
34.47
52-Week Low:
12.72

Prediction Charts

Market Cap:
2.5B
Price in USD:
14.46
Volume:
754.6K
Beta:
0.77

Technical Analysis

SMA50:
15.76
SMA100:
18.75
SMA200:
23.95
52-Wk Change:
-49.07%

Stock Predictions

  • Is Immunovant stock public?
    Yes, Immunovant is a publicly traded company.
  • What is the Immunovant stock quote today?
    The Immunovant stock price is 14.46 USD today.
  • How to buy Immunovant stock online?
    You can buy Immunovant shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
May-6 15.25 13.84 15.46 13.74
May-7 14.05 13.88 14.37 13.62
May-8 13.71 14.30 14.76 13.36
May-9 14.30 14.02 14.71 14.00
May-12 14.64 14.55 15.17 14.39
May-13 14.52 14.02 14.52 13.91
May-14 14.02 13.78 14.11 13.52
May-15 13.80 13.92 14.00 13.63
May-16 13.99 14.46 14.52 13.71
May-19 14.20 14.70 14.79 14.13
May-20 14.70 15.00 15.08 14.47
May-21 14.74 14.41 14.94 14.34
May-22 14.48 14.56 14.67 14.15
May-23 14.19 14.46 14.48 14.11

Immunovant Earnings

Immunovant Earnings Report: Per Share Immunovant Earnings Q1 Q2 Q3 and Q4 last year and next year.

Immunovant Forecast Revenue Growth

Immunovant Stock Analysis: Historical quarterly revenues per share for Immunovant and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.02 per share, a decrease this year of $1.13 per share, and a decrease next year of $0.02 per share.

* Immunovant stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.